Expanding Efforts Help Address Disparities in Lung Cancer Care

Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

A Roadmap to Improving Lung Cancer Care in the Middle East and North Africa

Managing lung cancer in the time of COVID-19

Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic

Lung Cancer Surgery in the COVID-19 Era: What Has Changed?

TERAVOLT: Increased Risk of Morbidity for Patients with Lung Cancer and COVID-19 Drives Research Collaboration

Leora Horn, MD - IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD - IASLC Virtual Presidential Symposium Presentation

Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations to Clinical Practice

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A With Dr. Benjamin Movsas